Brief: Saluda Medical Says FY26 Revenue Guidance Increased To $85 Million
28/01/2026 01:33
Jan 28 (Reuters) - Saluda Medical Inc SLD.AX: FY26 REVENUE GUIDANCE INCREASED TO US$85 MILLION Further company coverage: SLD.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Saluda Medical
See all newsBrief: Saluda Medical Initiates Voluntary Field Action For Certain Evoke® System Devices
Saluda Medical's shares hit record low on Evoke device recall
Australia's Saluda Medical hits record low on voluntary device field action
Brief: Saluda Medical Expands Access To FDA-Approved Closed-Loop Surgical Paddle Lead
Brief: Saluda Medical Appoints Mike Mathias As CEO Replacing Barry Regan